I slammed the 13d group often for not having a plan. They
I slammed the 13d group often for not having a plan. They went months without having a plan after revealing their intentions. They deserved to be slammed over and over. This is not a expectation that they should of ignored of having a plan.
When a group wants to take over a company you or I are invested in. Don’t you also expect a plan? Wouldn’t you expect that plan the day they notified everyone of their intentions to try to take over the company by getting on the BOD ballot? Wouldn’t a plan be something you would try to convince the investors that they need you to run the company? That you would be better at running the company than the current management? Their plan to date was very late coming and isn’t better than our current plan of growing into our own pharmaceutical company. This is the gold standard for all of us investors. Nothing could be better. We have that plan as a long term goal.
With no plan for months the 13d group put themselves in a deep hole to overcome. Then last month when they finally provided the smallest of plans that only goes out a years time… what does that say about a future direction of their plan for the company? One year and then they sell us to big Pharma for pennies on the dollar? Why only a one year out plan? This is not encouraging for any investor and I personally can’t see how anyone would vote for a group with a one year plan. Let alone their lack of experience and just how many lies have been exposed in their court settlement where they admitted their lies and conflicts of interest. This is not the group we need running our investment. Everyone should see this. Honesty is everything when dealing with money or investment.
Then to make that plan something that implies that they feel that the LH’ers trial will be our first approval? This also implies that the Brazil trials we most all believe will be our first approvals will then be stopped and all focus will be on LH’ers. They stated this much early on that all focus would be on the HIV BLA and they would stop everything else and all trials to focus on that. That plan changed and in their indecisiveness…changed to LH’ers. This doesn’t bode well for stability when you suggest a plan then change the plan so soon. It shows you there was never a real plan and in order to get support you just keep throwing the wet noodles against the wall until something sticks. In reality they are just not cut out to run a biotech and this much is obvious with their BOD candidates their lack of honesty and bashing campaign that shows they lack credibility.
Knowing what we know now about this 13d group and how honesty means nothing to them. This doesn’t give me the fuzzy warm feeling that they are here to save us. It tells me that they are untrustworthy and could be here for other reasons. Like self enrichment or just spite from previous bruised ego’s of why didn’t Cytodyn listen to us about this and that. Because with huge egos they think they know everything. Clearly they don’t. Their ineptness has shown through and now if you have followed the group. You know damn well they are not the choice for our investment and everyone should understand this. I don’t care if you don’t like Nader. He is far and away better than anyone from their slimy group of Candidates.
I am stepping down off my soap box now.
My hope is they don’t even make it on the ballot.
20
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...
Continue Reading
Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...
Continue Reading
Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...
Continue Reading
A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...
Continue Reading
A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...
Continue Reading
Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...
Continue Reading
Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...
Continue Reading
A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...
Continue Reading
Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...
Continue Reading
A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...
Continue Reading
Top 5 Most Recently Viewed Articles
Progyny Expands Women's Health Services with New Therapy Offerings Progyny, Inc. (Nasdaq: PGNY), a prominent leader in women's health and family building solutions, has announced a significant expansion of its services by adding pelvic floor therapy to its diverse array of offerings. This latest initiative underscores the company's commitment to enhancing healthcare...
Continue Reading
Revolutionizing Ambulatory Care with Innovative Technologies Greenway Health, a leader in health information technology, is set to change the landscape of ambulatory care with its groundbreaking introduction: The Automated Healthcare Practice. This innovative platform, unveiled at a major customer event, signifies a substantial transformation in the way healthcare is...
Continue Reading
Community Healthcare (NYSE:CHCT) is set to unveil its quarterly earnings on February 17, and the buzz is already electric. Analysts are projecting an earnings per share (EPS) of $0.47, a figure that's dancing right on the edge of what investors want to see. Now, here’s where it gets juicy: last time around, CHCT outperformed EPS expectations by a solid $0.33—but hold...
Continue Reading
Alphabet Inc's (NYSE:GOOGL) recent short interest report is making waves—short interest as a percent of float dropped by 9.03%. That leaves us with 75.95 million shares sold short, which amounts to about 1.31% of all regular trading shares available. And here's the kicker: based on current trading volume, it would take traders an average of 2.48 days to cover their...
Continue Reading
Analyzing AppLovin Inc's Stock Performance As the market evolves, investors keep a close eye on stock prices. Currently, AppLovin Inc. (NASDAQ: APP) is trading at $683.87, reflecting a slight increase of 1.97%. This upward trend has caught the attention of both short-term traders and long-term shareholders. Over the past month, the stock achieved a remarkable increase of...
Continue Reading